Acacia Acquires Rights To Patent For Biosensor Technology

Acacia Research has announced that its subsidiary, Acacia Patent Acquisition, has acquired rights to a patent for biosensor technology.

The patented technology generally relates to biosensors, such as those used in drug discovery.

Paul Ryan, chairman and CEO of Acacia, said: “Acacia continues to grow its base of future revenues by adding new patent portfolios. As our licensing success grows, more patent owners are selecting us as their partner for the licensing of their patented technologies.”

Acacia Research’s subsidiaries develops, acquires, and licenses patented technologies. Acacia Research’s subsidiaries control over 100 patent portfolios, covering technologies used in a wide variety of industries.